Compounds > n-benzoyloxy-n-methyl-4-aminoazobenzene
Page last updated: 2024-11-06

n-benzoyloxy-n-methyl-4-aminoazobenzene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID80192
SCHEMBL ID3340470
MeSH IDM0054677

Synonyms (21)

Synonym
unii-o0ck37yf3a
o0ck37yf3a ,
brn 1844284
ccris 803
benzoyloxy-mab
o-benzoyl-n-methyl-n-(p-(phenylazo)phenyl)hydroxylamine
n-(benzoyloxy)-n-methyl-4-(phenylazo)benzenamine
benzenamine, n-(benzoyloxy)-n-methyl-4-(phenylazo)-
n-benzoyloxy-n-methyl-4-aminoazobenzene
hydroxylamine, o-benzoyl-n-methyl-n-(p-(phenylazo)phenyl)-
6098-46-0
(n-methyl-4-phenyldiazenylanilino) benzoate
SCHEMBL3340470
4-(n-(benzoyloxy)-n-methylamino)azobenzene
benzoic acid, methyl(4-(2-phenyldiazenyl)phenyl)azanyl ester
benzoyloxy)-n-methyl-4-(phenylazo)benzenamine, n-(
n-(benzoyloxy)-n-methyl-4-aminoazobenzene
n-benzoyloxy-n-methyl-4-(phenylazo)benzenamine
Q27890214
DTXSID901039766
benzoic acid, methyl[4-(2-phenyldiazenyl)phenyl]azanyl ester
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.50

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.50 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.50)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
2-acetylaminofluorene
2-Acetylaminofluorene: A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines.		6.96102-acetamidofluorenesantimitotic;
carcinogenic agent;
epitope;
mutagen
p-aminoazobenzene
p-Aminoazobenzene: Used in the form of its salts as a dye and as an intermediate in manufacture of Acid Yellow, diazo dyes, and indulines.. 4-(phenylazo)aniline : Azobenzene substituted at one of the 4-positions by an amino group. It has a role as a dye and an allergen.		3.2160
n-methyl-4-aminoazobenzene
N-methyl-4-aminoazobenzene: structure		2.6530
acetoxyacetylaminofluorene
Acetoxyacetylaminofluorene: An alkylating agent that forms DNA ADDUCTS at the C-8 position in GUANINE, resulting in single strand breaks. It has demonstrated carcinogenic action.. N-acetoxy-2-acetamidofluorene : A 2-acetamidofluorene compound in which the parent 2-acetamidofluorene is substituted on nitrogen by an acetoxy group.		1.96102-acetamidofluorenescarcinogenic agent;
mutagen
deoxyguanosine
[no description available]		6.9510purine 2'-deoxyribonucleoside;
purines 2'-deoxy-D-ribonucleoside		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
guanosine
ribonucleoside : Any nucleoside where the sugar component is D-ribose.		6.9510guanosines;
purines D-ribonucleoside		fundamental metabolite
ConditionIndicatedRelationship StrengthStudiesTrials